A Focus on Supportive Care: Strategies to Improve Nausea and Vomiting in Cancer Patients

Chemotherapy-induced nausea and vomiting (CINV) is a serious problem that can negatively impact a cancer patient’s quality of life and affect the timely deliver and ability to give the most effective doses of the chemotherapy treatment.

Target Audience

This activity is designed for oncology healthcare providers (oncologists, oncology nurses, and oncology physician assistants) who care for patients with CINV. No prerequisites required.

Learning Objectives

After participating in this activity, the participant will demonstrate the ability to:

  • RECOGNIZE the impact untreated CINV has on chemotherapy adherence and overall patient outcomes.
  • ASSESS patient-specific and therapy-specific CINV risk factors.
  • IDENTIFY current and emerging antiemetics used as single agents or in combination therapy for CINV.
  • APPLY evidence-based strategies to prevent and manage CINV in patients receiving moderately or highly emetogenic chemotherapy regimens
Additional information
Contact email: 
Course summary
Available credit: 
  • 0.50 ANCC
Registration opens: 
Registration closes: 

Susan Urba, MD
Professor of Internal Medicine
Division of Hematology/Oncology
Medical Director, Symptom Management and Supportive Care Program
University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan 


The Institute for Johns Hopkins Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Available Credit

  • 0.50 ANCC


Please login or register to take this course.